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AbstrACt
Objective To identify potentially effective complementary 
approaches for musculoskeletal (MSK)–mental health (MH) 
comorbidity, by synthesising evidence on effectiveness, 
cost-effectiveness and safety from systematic reviews 
(SRs).
Design Scoping review of SRs.
Methods We searched literature databases, registries 
and reference lists, and contacted key authors and 
professional organisations to identify SRs of randomised 
controlled trials for complementary medicine for MSK or 
MH. Inclusion criteria were: published after 2004, studying 
adults, in English and scoring >50% on Assessing the 
Methodological Quality of Systematic Reviews (AMSTAR); 
quality appraisal checklist). SRs were synthesised to 
identify research priorities, based on moderate/good 
quality evidence, sample size and indication of cost-
effectiveness and safety.
results We included 84 MSK SRs and 27 MH SRs. 
Only one focused on MSK–MH comorbidity. Meditative 
approaches and yoga may improve MH outcomes in 
MSK populations. Yoga and tai chi had moderate/good 
evidence for MSK and MH conditions. SRs reported 
moderate/good quality evidence (any comparator) in 
a moderate/large population for: low back pain (LBP) 
(yoga, acupuncture, spinal manipulation/mobilisation, 
osteopathy), osteoarthritis (OA) (acupuncture, tai chi), 
neck pain (acupuncture, manipulation/manual therapy), 
myofascial trigger point pain (acupuncture), depression 
(mindfulness-based stress reduction (MBSR), meditation, 
tai chi, relaxation), anxiety (meditation/MBSR, moving 
meditation, yoga), sleep disorders (meditative/mind–body 
movement) and stress/distress (mindfulness). The majority 
of these complementary approaches had some evidence of 
safety—only three had evidence of harm. There was some 
evidence of cost-effectiveness for spinal manipulation/
mobilisation and acupuncture for LBP, and manual therapy/
manipulation for neck pain, but few SRs reviewed cost-
effectiveness and many found no data.
Conclusions Only one SR studied MSK–MH comorbidity. 
Research priorities for complementary medicine for both 
MSK and MH (LBP, OA, depression, anxiety and sleep 
problems) are yoga, mindfulness and tai chi. Despite the 
large number of SRs and the prevalence of comorbidity, 
more high-quality, large randomised controlled trials in 
comorbid populations are needed.
IntrODuCtIOn   
Musculoskeletal (MSK) and mental health 
(MH) disorders are two conditions resulting 
in some of the highest burden in terms of 
disability, accounting for 30.5% and 21.1% of 
years lived with disability, respectively.1 Both 
affect one in four UK adults at some point in 
their life.2–4 MSK disorders lead to very high 
healthcare expenditure and loss of work,5 in 
the UK accounting for 7.5 million working 
days lost annually6 and 60% of occupational 
sick leave.2 In England, it has been estimated 
that MH costs £105 billion, and treatment 
costs are expected to rise substantially.7 
Low back pain (LBP) is one of the most 
common health conditions,8–10 with a mean 
global general population prevalence (regard-
less of prevalence period) of 31%10 and a UK 
prevalent population of 17.3 million, with 
3.1 million adults suffering during an entire 
year,11 costing the National Health Service 
(NHS) over £500 million/year.12 In the UK, 
8.75 million people sought primary care treat-
ment for osteoarthritis (OA) (over a 7-year 
strengths and limitations of this study
 ► A comprehensive scoping review covering a wide 
range of individual musculoskeletal and mental 
health conditions, in the notable dearth of system-
atic reviews (SRs)/randomised controlled trials in 
comorbid populations.
 ► This review used systematic searching and screen-
ing techniques.
 ► Results are limited by our pragmatic choice to only 
include high-quality  SRs (high scoring on AMSTAR 
checklist (Assessing the Methodological Quality 
of Systematic Reviews)) and definition of comple-
mentary medicine as including a practitioner in its 
delivery.
 ► Date and language limitations may have excluded 
some topics.
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consultation period)13 which is estimated to have resulted 
in £14.8 billion indirect costs.14
The most common MH conditions are depression and 
anxiety.3 4 In England, 19% of the general adult popu-
lation reported ever being diagnosed with depression 
and 6% ever being diagnosed with generalised anxiety 
disorder.15 Insomnia is another common MH problem, 
affecting 6.4% of the UK general population.16
There is an increasing recognition of the importance 
of multimorbidity, that is, the coexistence of two or more 
physical and/or mental long-term conditions in an indi-
vidual, which is becoming the norm in the UK.17–19 In a 
cross-sectional study in Scotland, 8.3% of primary care 
patients (36% of those with multimorbidity) had both a 
physical and a MH disorder20 and around 50% of patients 
with depression had pain symptoms.21 Long-term MSK 
disorders are closely associated with multimorbidity.22
Complementary medicine is ‘a diverse group of 
health-related therapies and disciplines which are not 
considered to be a part of mainstream medical care’, 
including osteopathy, chiropractic, acupuncture, herbal 
medicine and homeopathy.23 Estimates of 12-month prev-
alence of use of any complementary medicine are 0.3%–
86% in Europe24 and 26% in England.25
Many MSK and MH conditions, and comorbid MSK 
and MH, have limited conventional treatment options, 
‘effectiveness gaps’, which are potential key areas for 
complementary medicine.26 27 Both MH28–30 and MSK24 31 
are common reasons for patients to use complementary 
medicine. We used scoping methodology to identify 
priority areas where complementary medicine may be 
useful.32 The overall aim of scoping studies is ‘to map 
rapidly the key concepts underpinning a research area 
and the main sources and types of evidence available’ in 
a formal, systematic and transparent way (which is often 
lacking in research priority setting exercises).33 Scoping 
study methodology was used to identify gaps in the 
research base and priorities for future research. Scoping 
work is an essential step in the development of a strategy 
for the integration of complementary medicine with 
conventional care.27 Preliminary searches showed that 
evidence for comorbid populations was very limited, so 
we chose to include independent evidence on MSK and 
MH conditions. This review was part of a wider scoping 
study, which obtained a breadth of perspectives—the 
results of this review were combined with findings from 
consultation with conventional and complementary 
medicine practitioners, a public survey and case studies 
of NHS provision of complementary medicine, to inform 
the final choice of conditions and complementary medi-
cine approaches for a randomised controlled trial (RCT).
MethODs
The scoping study followed Arksey and O’Malley’s32 
framework plus the refinements suggested by Levac et 
al,34 Daudt et al35 and Colquhoun et al.36 Scoping reviews 
are broader and more exploratory than systematic reviews 
(SRs). They review a large number of papers to map the 
evidence—focussing on breadth rather than detail; have 
few preconceived ideas regarding focus (particularly types 
of MSK/MH in this context); do not necessarily assess 
individual study quality; and use a narrative approach to 
analysis, rather than synthesising or aggregating quantita-
tive data.32 The reader is advised to refer to the original 
SRs we have included for more detailed content.
Aims
This study aimed to identify which practitioner-based 
complementary approaches have evidence for both 
MSK disorders and MH conditions in order to identify 
research priorities in terms of treatment choice and 
specific patient groups/conditions for a future prag-
matic trial of comorbid MSK and MH in UK primary 
care. The specific aims were to:
 ► Collate the evidence on effectiveness, cost-effective-
ness and safety from recent SRs of trials of comple-
mentary medicine for MSK and MH conditions.
 ► Identify areas where there is high-quality evidence of 
effectiveness but sufficient uncertainty to justify a trial.
 ► Identify areas where there is also some evidence of 
cost-effectiveness and safety.
searches
As this was a scoping review, we used a wide range of 
methods to identify SRs (published, unpublished, in 
progress). Literature databases were searched (see below 
for details of searches): AMED, Medline, EMBASE, 
CINAHL, PsycINFO; Index to theses; Cochrane library; 
Epistemonikos; SIGLE. Three trial registries were 
searched (UKCRN, Health service research projects in 
progress, Prospero). Reference lists of ‘overviews of SRs’ 
and reports (from professional/patient organisations) 
were searched. We emailed key authors in the field. 
We also asked the project team, steering group and 
public and patient involvement (PPI) group, and used 
websites/social media (university websites, Research 
Gate and Twitter) to access the wider research commu-
nity. We asked patient and professional organisations to 
ask their members for any information (by email, news-
letters or social media). These included: disease-spe-
cific organisations, for example, Arthritis Research UK, 
Back Care and MIND; complementary medicine organ-
isations, for example, Research Council for Comple-
mentary Medicine and Complementary and Natural 
Healthcare Council; primary care organisations, for 
example, UK Royal College of General Practitioners. 
We presented at one conference and distributed a flyer 
at another. We contacted the authors of eligible confer-
ence abstracts and protocols to ascertain if the SR was 
available, that is, submitted or in press.
For complementary medicine, we used MeSH terms 
or subject headings, plus additional terms for comple-
mentary medicine which were not indexed. To ensure 
relevance to UK primary care, we only included comple-
mentary approaches which involve practitioner-led 
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treatment. We therefore excluded herbal medicine, 
as the majority of studies do not involve a practi-
tioner. We included manipulation, manual therapy 
and mobilisation as techniques commonly practised by 
some complementary medicine practitioners (as well 
as conventional practitioners). For MSK conditions, 
we used ‘musculoskeletal diseases/disorders’ as index 
terms, adding in any which were missing. For MH, we 
searched for common, minor MH disorders and symp-
toms, excluding long-term/severe mental illnesses. 
Thus, words in titles/abstracts were searched for (rather 
than subject headings), with reviews needing to include 
patients with MH symptoms/diagnoses rather than just 
measuring MH outcomes. See online supplementary 
appendix 1 for a full list of included and excluded non 
MSK or MH conditions.
Database searches were conducted in June 2015 
and updated in February 2016, in collaboration with a 
librarian. We used filters for SRs. We excluded reviews 
published pre-2005, in order to make the final number 
of papers manageable with minimal impact on our 
results (given that the majority of SRs were published 
in 2010 and after (122/158 SRs)). We only included 
English language reviews. Databases were searched for 
two topics: complementary medicine+musculoskeletal 
disorders and complementary medicine+mental health. 
See online supplementary appendix 1 for details and 
supplementary appendix 2 for an example search.
We used the inclusion/exclusion criteria (see online 
supplementary appendix 1) to screen the results from 
each search. This was a multistage process involving the 
whole project team. AL screened the titles of all search 
results, and DS checked the results, with any disagree-
ments discussed and inclusion criteria amended accord-
ingly. AL then screened the abstracts, which were also 
independently screened by another author. Results were 
compared, any disagreements discussed and the criteria 
again amended accordingly. Any remaining disagree-
ments were discussed and resolved with a third author. 
AL then screened the full text of the agreed papers.
Data extraction
AL extracted the following data from each SR: author, 
year, location, complementary medicine/s, health condi-
tion/s, for MSK reviews whether MH was included and 
for MH reviews whether findings applied to MSK popu-
lations, methodological features (sources searched, 
inclusion/exclusion criteria, quality assessment), 
results and conclusions (effectiveness, safety, cost-effec-
tiveness). Where possible, these data were copied and 
pasted directly, to avoid any misinterpretation.
Quality appraisal of srs
Although not essential,32 quality assessment is recom-
mended in scoping reviews.37 We used a limited quality 
appraisal of SRs to help inform prioritisation, using 
AMSTAR (Assessing the Methodological Quality of 
Systematic Reviews), a validated checklist.38 Due to time 
constraints and the number of SRs to be appraised, a 
simple procedure was followed, using the ‘search’ func-
tion in the text of SRs to find particular terms. The 
emphasis was on obtaining relative scores, allowing 
ranking of the included reviews, rather than an abso-
lute score of quality. For each of the 11 items on the 
AMSTAR checklist, a score of 0 was given if they did 
not meet the criteria or  if information was unavailable, 
a score of 1 if the criteria was met. The scores were 
summed to give a score for each SR out of a total of 11.
Any reviews which scored 5 or less (half of the possible 
total) on AMSTAR were not considered in the evidence 
synthesis.
evidence synthesis
In line with Arksey and O’Malley’s32 framework for 
conducting scoping reviews, we used a ‘descriptive‐
analytical’ method, based on the narrative tradition, 
applying a common analytical framework to the reviews. 
Evidence synthesis was performed by AL and all authors 
met regularly to discuss the process and emerging 
results.
Reviews were placed into a matrix of health condition/
symptom versus complementary medicine, for example, 
LBP and acupuncture (see tables 1 and 2).
Where there was more than one SR in an area, one 
(occasionally more than one—where they studied 
different interventions, eg, types of manipulation) was 
prioritised, based on recency, breadth, quality (AMSTAR 
score) and level of analysis (eg, meta-analysis).
There were three steps to the evidence synthesis: 
step 1: extraction and narrative synthesis of data from 
prioritised SRs: step 2: ranking of areas (condition vs 
complementary medicine) using an Excel framework 
(see below for ranking criteria); and step 3: computa-
tion of sample size.
Step 1 data extraction
For each area (condition vs complementary medicine) in 
the matrix, data were synthesised for:
 ► Effectiveness: the conclusions on effectiveness were 
extracted from the prioritised SR/s, including infor-
mation on comparator and outcomes.
 ► Quality of studies: in line with guidance on scoping 
reviews,32 we did not assess the quality of the indi-
vidual RCTs in each SR, but synthesised the SR 
authors’ conclusions about quality, from the prior-
itised review/s. We had three categories of quality: 
poor, moderate or good. Moderate included SRs 
reporting mixed results.
 ► Safety: any information on safety was synthesised 
across all the included SRs.
 ► Cost-effectiveness: any information on cost-effective-
ness was synthesised across all the included SRs.
Step 2 ranking
Using the information extracted in step 1, we ranked 
the areas in the matrix (condition vs complementary 
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medicine), based on consideration of the following 
criteria:
1. Effectiveness: areas were ranked highly where there 
was enough moderate/good quality evidence to estab-
lish proof of concept, but still key gaps. Data on effec-
tiveness came from the conclusions of the prioritised 
SRs regarding effectiveness and quality.
2. Safety: areas where there was evidence of harm were 
ranked lower.
3. Cost: areas where there was any indication that the 
intervention may have potential for cost-effectiveness 
were ranked highly.
4. Comorbidity: any interventions that showed an indica-
tion (of any quality) for comorbid MH and MSK pa-
tients were ranked highly.
Step 3 sample size
Once a ranked list of areas had been compiled, infor-
mation on total sample size for the prioritised SR/s (ie, 
total number of participants in the trials included in 
the SR/s) was added to allow further discrimination, 
classified as: small (<500 participants), medium (501 to 
3000) or large (>3000).
Patient and public involvement
The wider scoping study included a PPI group of seven 
people with experience of MSK/MH issues, who advised 
the research team on a variety of issues as the study 
took shape and progressed. They met four times over 
the study period and provided input into the literature 
review questions, search strategy and selection criteria. 
Table 2 Matrix of mental health reviews (numbers=number of reviews)
Depression Anxiety Stress Insomnia/sleep
Distress 
(psychological)
Total*
Total 
number
High 
quality
Total 
number
High 
quality
Total 
number
High 
quality
Total 
number
High 
quality
Total 
number
High 
quality
Acupuncture-related 
  Acupuncture 9 3 2 1 2 1 6 
Auricular acupuncture 3 1 4
Multiple 
  Complementary 
medicine (multiple) 
(did not separate 
complementary 
medicine in analysis)
1 0 1 0 2 1 4
Meditation/mindfulness 
  Mindfulness 3 2 1 1 1 1 1 1 5
  Meditation 3 3 1 1 1 0 9
Exercise 
  Meditative movement 3 3 6
  Qigong 4 1 2 1 1 1 5
  Tai chi 4 2 1 0 3 1 5
  Yoga 4 2 3 3 1 0 1 0 8
Other 
  Homeopathy 1 1 2
  Hypnosis 2 0 2 2 4
  Music therapy 3 2 1 1 2
  Relaxation 3 1 1 1 1 1 4
  Reflexology 1 0 1
  Reiki 1 1 1 1 2
  Spinal manipulation 0
  Massage/therapeutic 
touch
2 1 2 2 4
  Morita therapy 1 1 2
Total* 36 15 19 15 4 3 20 11 1 1 48 (27)
*Note that reviews can occur in more than one row/column
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The PPI group also provided ideas on ways to dissemi-
nate the findings to the general public and to patient 
groups.
results
search results
Figure 1 shows the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses flowchart of the searches.39 
Searches resulted in 8393 references—4304 for MH and 
4089 for MSK, plus three for MH identified elsewhere 
(email update sent by journal publisher). After removing 
duplicates, Cochrane reviews which were withdrawn, 
Cochrane reviews which had been updated or those not 
in English, 5230 records remained for title screening. 
This resulted in 486 MH and 739 MSK records for the 
abstract screening phase. We then excluded 49 (13 MH 
and 36 MSK) records, that is, editorials, commentaries, 
abstracts etc. After abstract screening, there remained 
444 studies (180 MH and 264 MSK). At this stage, a 
further 12 records were added—three from grey litera-
ture (Prospero/Sigle/HSRProj), five from conference 
abstracts and four from the reference lists of overviews of 
SRs and other key reports. This produced 456 records to 
be screened at the full-text stage, after which 206 records 
remained: 48 MH, 158 MSK.
During screening at the title stage (AL and DS), there 
were 49 disagreements (out of 4411 records; 1%). During 
abstract screening (AL and each of the six authors), there 
were a total of 296 initial disagreements (out of 1165 
records; 25%). Most were resolved by discussion without 
requiring a third reviewer.
Of the 158 MSK SRs, 84 were included as high quality 
(scored six or more on AMSTAR): LBP,40–69 fibro-
myalgia,70–81 neck pain,40 82–90 OA,91–101 rheumatoid 
arthritis,97 102–105 general MSK pain/conditions,106–110 
shoulder pain/disorders,111–115 myofascial trigger point 
pain106 116 117 and other musculoskeletal (MSK) condi-
tions.106 118–123
The 158 reviews covered 17 different and 15 different 
disorders. The overall matrix is shown below in table 1. 
LBP was by far the most common topic, addressed by 
64/158 (40%) of reviews. Fibromyalgia was the next most 
common, followed by OA then neck pain/disorders. 
Acupuncture was the most common complementary 
medicine studied (58/158 SRs; 37%), followed by manual 
therapy (including manipulation and mobilisation). The 
mean AMSTAR score for methodological quality of MSK 
reviews was 6/11 (ranging from 0 to 11). Online supple-
mentary appendix 3 shows which items on the AMSTAR 
checklist were reported by the reviews.
Of the 48 MH SRs, 27 were high quality (scored six or more 
on AMSTAR): depression,124–134 anxiety,124 125 129 133 135–142 
sleep,143–150 stress124 125 140 and other.124 The 48 reviews 
covered 18 different and five different categories of 
MH symptom or disorder. The overall matrix is shown 
in table 2. Many of the reviews included more than one 
MH condition. Of the 48 reviews, 36 (75%) included 
depression. Meditation, yoga, acupuncture and medi-
tative movement were the most common complemen-
tary medicine. Online supplementary appendix 3 shows 
which items on the AMSTAR checklist were reported by 
the reviews.
The following sections present a summary of the areas 
where we found moderate/good quality evidence of effec-
tiveness (from the prioritised SRs). For those conditions 
with evidence for more than one intervention, we have 
presented the results in tables.
evidence for MsK disorders
The areas where there was moderate/good quality 
evidence were LBP, myofascial trigger point pain, OA, 
neck pain, fibromyalgia and lateral epicondylitis. It 
should be noted that the SR quality of evidence is based 
on the overall assessment of quality of the included RCTs 
by the SR authors, which is subject to some limitations.
Low back pain
Moderate/good quality evidence for LBP (see table 3) 
was found as follows:
 ► Yoga: four high-quality reviews,51 60–62 one prioritised62
 ► Osteopathy: two high-quality reviews,64 65 one 
prioritised65
 ► Acupuncture: six high-quality reviews,40 41 49 50 53 54 two 
prioritised—as highest quality40 and most recent50
 ► Spinal manipulation/mobilisation: nine high-quality 
reviews,40–48 three prioritised (due to differences in 
types of back pain and interventions included)40 43 44
 ► Spa/balneotherapy: one high-quality review52
 ► Tai chi: one high-quality review54
Osteoarthritis
Moderate/good quality evidence for OA (see table 4) was 
found as follows:
 ► Acupuncture: six high-quality reviews,91–96 two priori-
tised92 as a Cochrane review and94 as most recent.
 ► Tai chi: five high-quality reviews,97–101 one prioritised/99
Neck pain
Moderate/good quality evidence for neck pain (see 
table 5) was found as follows:
 ► Manual therapy/manipulation: eight high-quality 
reviews,40 82–88 three were prioritised due to differing 
inclusion criteria.82 87 88
 ► Acupuncture: two high-quality reviews,40 89 one 
prioritised.89
There was moderate quality evidence in a medium-sized 
population for a range of other techniques.82 87 88
Fibromyalgia
Acupuncture for fibromyalgia was reviewed by—five 
high-quality reviews,70–73 81 one prioritised.72 The prior-
itised review found moderate quality evidence in a 
small population compared with placebo for stiffness 
(acupuncture) and for pain and sleep disorders (elec-
troacupuncture). However, there was some evidence 
that acupuncture is less effective than usual care for 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart. MH, mental health; MSK, 
musculoskeletal; SR, systematic review.
 o
n
 18 Decem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020222 on 15 October 2018. Downloaded from 
8 Lorenc A, et al. BMJ Open 2018;8:e020222. doi:10.1136/bmjopen-2017-020222
Open access 
MH outcomes in fibromyalgia.72 There is some evidence 
of safety (no serious adverse events)70–73 81 but none of 
cost-effectiveness.
Myofascial trigger point pain
Acupuncture for myofascial trigger point pain was 
reviewed by—three high-quality reviews.106 116 117 The 
prioritised review found good quality evidence in a medi-
um-sized population compared with placebo and other 
active interventions for pain in the short and medium 
term but not in the long term.117 However, safety, 
cost-effectiveness or impact on MH outcomes were not 
reported.106 116 117
Lateral epicondylitis
One high-quality review120 found moderate quality 
evidence for manual therapy (mobilisation with 
movement) but the comparator and sample size were not 
reported so we are unable to include it in our synthesis.
evidence for mental health
No reviews provided good quality evidence for comple-
mentary medicine for any MH condition nor any evidence 
of cost-effectiveness, mainly because the latter was not 
reported.
Depression
Moderate quality evidence for depression (see table 6) 
was found as follows:
 ► Mindfulness/meditation: two high-quality 
reviews,124 125 both prioritised as included different 
types of meditation/mindfulness/mindfulness-based 
stress reduction (MBSR) or populations.
Table 3 Evidence for low back pain
Comparator Quality
Population 
size Complementary medicine Safety Cost-effectiveness
Active 
intervention
Good Medium Osteopathy65 Some evidence of harm65* NR
Moderate Large Spinal manipulation/
mobilisation (chronic 
only)40 43 44
Some evidence of safety44† Mixed results—some 
evidence of CE47‡
Moderate Medium Yoga62 Some evidence of safety51 60 62§ No data
Moderate Small Balneotherapy52 Some evidence of safety52 NR
Usual care Moderate Large Acupuncture40 50 (for pain, 
function, well-being, disability, 
range of movement , quality 
of life)
Some evidence of safety53 54¶ Some evidence of 
CE40**
Moderate Small Spa therapy52 Some evidence of safety52†† NR
Tai chi54 NR NR
Placebo Moderate Large Acupuncture (for pain and 
quality of life; negative 
evidence for disability).40 50
Some evidence of safety53 54¶ Some evidence of 
CE40**
*Two studies reported minor adverse events.
†One review identified serious adverse events, but this appeared unrelated to treatment. Minor adverse events included muscle soreness, 
stiffness and/or transient increase in pain.
‡Mixed results regarding cost-effectiveness,40 with limited evidence that manual therapy is more cost-effective than usual care.47
§No serious adverse events associated with the yoga.
¶5% minor adverse events and no serious adverse events.
**Short-term only.
††No adverse events from one study.
CE, cost effectiveness; NR, not reported (by systematic reviews).
Table 4 Evidence for osteoarthritis
Comparator Quality
Population 
size Complementary medicine Safety Cost-effectiveness
Placebo Good Large Acupuncture92 94* Some evidence of harm91 92† NR
Usual care Moderate Small Tai chi99‡ Some evidence of safety98–100§ NR
*Compared to pulsed electromagnetic fields, muscle-strengthening or aerobic exercise, weight loss.
†Up to 45% frequency of minor adverse events.
‡Only in the short term.
§Systematic reviews (SRs) concluded tai chi is safe.
NR, not reported (by SRs).
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 ► Tai chi: two high quality reviews,132 134 both prioritised 
as Chi et al134 only reviewed studies of older people 
(Liu et al132 found only poor quality evidence).
 ► Relaxation: one high-quality review129 but comparator 
and sample size were not reported so it is not included 
here.
Anxiety
Moderate quality evidence for anxiety (see table 7) was 
found as follows:
 ► Meditation, including moving meditation (yoga, tai 
chi and qi gong): three high-quality reviews,125 137 138 
one prioritised.138
 ► MBSR: one high-quality review.124
 ► Yoga: three high-quality reviews,129 135 136 one 
prioritised.136
Sleep disorders
Three high-quality reviews considered meditative/
mind–body movement for sleep.143–145 The prioritised 
review found moderate quality evidence in older adults 
for meditative movement in a medium-sized population, 
compared with usual care and other active interven-
tions.143 There was some evidence of safety (no adverse 
events)143 and effect on sleep quality in an MSK popula-
tion.145 No cost-effectiveness data reported.
Stress and distress
There was one high-quality review of mindfulness for 
stress and distress.124 For stress, they found moderate 
quality evidence in a medium-sized population compared 
with usual care and placebo, and some evidence of effec-
tiveness on stress as an outcome in an MSK population.124 
There were no data on cost-effectiveness and no data on 
safety. For distress, they found moderate quality evidence 
in a medium-sized population compared with usual care, 
and some evidence of effectiveness on distress as an 
outcome in an MSK population.124 There were no data 
on cost-effectiveness and safety was not reported.
There was only poor quality evidence for all other combi-
nations of MH condition/complementary medicine/
comparator.
evidence for effectiveness in comorbidity/Mh outcomes in 
MsK
Only one SR provided data on comorbid MSK and MH 
conditions (depression and a variety of comorbid MSK 
conditions).132 Three SRs provided data on MH outcomes 
in MSK populations (but did not specify an MH score/
diagnosis as inclusion criterion). Tai chi for depression 
and comorbid conditions (including MSKs) may be less 
effective than for depression alone132; MBSR/meditation 
Table 5 Evidence for neck pain
Comparator Quality
Population 
size
Complementary 
medicine Safety Cost-effectiveness
Active 
intervention
Good Medium Manual therapy87* Some evidence of potential harm82 83† Some evidence of CE87 88‡
Moderate Large Manipulation82§¶ Some evidence of potential harm82 83† Some evidence of CE87 88‡
Moderate Small Manual therapy88** Some evidence of potential harm82 83† Some evidence of CE87 88‡
Placebo Moderate Medium Acupuncture89 Some evidence of safety89 No data40
Usual care Moderate Medium Acupuncture89 Some evidence of safety89 No data40
*Manual therapy plus exercise compared with exercise alone.
†Reduced cost of therapy.
‡Minor adverse events and rare but devastating adverse effects from manipulation.
§Compared to medication.
¶Also showed effectiveness for pain compared with any control.
**Mobilisation, manipulation and soft tissue techniques.
CE, cost effectiveness.
Table 6 Evidence for depression
Comparator Quality
Population 
size Complementary medicine Safety
Cost-
effectiveness
Active intervention Moderate Medium Meditation125* Some evidence of safety§ 
125
No data124
Usual care Moderate Medium MBSR (mindfulness-based 
stress reduction)124*
Some evidence of safety§ 
125
No data124
Moderate Medium Tai chi134†‡ No data134 No data134
*Also some evidence of effectiveness for both in musculoskeletal (MSK) populations.124 125
†Older adults only.
‡May be less effective in comorbid populations (including some MSK conditions).132
§Nine trials found no adverse events.
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was effective for MH outcomes (depression, anxiety, 
stress/distress) in an MSK population124 125; meditative/
mind–body movement was effective for sleep outcomes in 
an MSK population.145
Complementary medicine with evidence for both MsK and Mh 
conditions
From the above synthesis, complementary medicine 
with moderate/good quality evidence for both MSK and 
MH conditions (from separate SRs) are yoga and tai chi. 
Yoga appears to be effective for both LBP and anxiety 
compared with other active interventions, although the 
anxiety finding was only from studies of women with 
breast cancer. Meditative movement, which includes yoga, 
is effective for sleep disorders, although only for older 
adults (there is also some evidence in chronic pain and 
fibromyalgia populations). Tai chi appears to be effective 
compared with usual care for LBP, knee OA and depres-
sion, in older people (although it appears less effective 
in comorbid depressed patients). Meditative movement, 
which includes tai chi, is effective for sleep disorders, 
although only for older adults (there is some evidence in 
chronic pain and fibromyalgia populations as well).
update
Since completing this review, in July 2017, we searched 
for recent SRs on the highest ranking topics (results are 
not included in tables 3-7). These either provide addi-
tional evidence for MH outcomes in an MSK population, 
or evidence supporting our original conclusions.
 ► Yoga: a new Cochrane review for LBP has been 
published which suggests there is moderate-quality 
evidence for yoga compared with other active inter-
ventions for pain, and for function at 6 months only, 
although they also found moderate-quality evidence 
of harm for yoga (primarily exacerbation of back 
pain).151 They also found very low-quality MH evidence 
for yoga improving depression (as an outcome not a 
diagnosis) in LBP (comparator not stated).151
 ► MBSR/mindfulness/meditation: a new SR provides 
evidence for mindfulness and MH, including high-
quality evidence (sample size not reported) for mind-
fulness helping with depression (compared with 
all controls—usual care, and active interventions 
(education, stress management); (as an outcome not 
a diagnosis) in LBP (and fibromyalgia).152 Another 
SR of mindfulness for LBP was recently published 
but cannot be included as there were no conclusions 
regarding study quality.153
 ► Acupuncture (compared with other active inter-
ventions): Two new SRs confirm the effectiveness 
of acupuncture for OA of the knee, with moder-
ate-quality evidence in a large sample compared with 
active interventions and placebo.154 155
DIsCussIOn
This scoping review has highlighted the large and 
increasing number of SRs of complementary medi-
cine for MSK and MH disorders, covering 29 different 
complementary medicine approaches, but identified no 
high-quality evidence for complementary medicine for 
MSK–MH comorbid populations. Three reviews showed 
that MBSR/meditation/meditative movement may 
improve MH outcomes in MSK populations. Acupunc-
ture, yoga, tai chi and mindfulness/meditation have 
evidence for both MSK and MH conditions.
We have identified moderate/good-quality evidence 
(as reported by SR authors) for effectiveness (any 
comparator) in a moderate/large population for: 
LBP (yoga, acupuncture, spinal manipulation/mobil-
isation, osteopathy), OA (acupuncture, tai chi), neck 
pain (acupuncture, manipulation/manual therapy), 
myofascial trigger point pain (acupuncture), depression 
(MBSR, meditation, tai chi, relaxation), anxiety (medi-
tation/MBSR, moving meditation, yoga), sleep disor-
ders (meditative/mind–body movement) and stress/
distress (mindfulness). The majority of these comple-
mentary approaches had some evidence of safety—
only three had evidence of harm—osteopathy for LBP, 
acupuncture for OA and manipulation/manual therapy 
for neck pain. There was some evidence of cost-effective-
ness for spinal manipulation/mobilisation and acupunc-
ture for LBP, and manual therapy/manipulation for 
neck pain, but few SRs reviewed cost-effectiveness and 
many found no data.
Table 7 Evidence for anxiety
Comparator Quality Population size
Complementary 
medicine Safety
Cost-
effectiveness
Active intervention Moderate Medium Meditation138*† Some evidence of safety125 137 138 NR
Moderate Medium Yoga136‡ No data135 NR
Placebo Moderate Medium Meditation138*† Some evidence of safety125 137 138 NR
Usual care Moderate Medium Meditation138*† Some evidence of safety125 137 138 NR
Moderate Medium MBSR124† Some evidence of safety125 137 138 NR
*Moving meditation (tai chi, qi gong or yoga) was more effective than static meditation.
†Mindfulness-based stress reduction (MBSR)/meditation was also effective for anxiety (as an outcome) in a musculoskeletal population.124 125
‡For women with breast cancer only.
NR, not reported (by systematic reviews).
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Regarding comorbidity, from our original searches, the 
only evidence for MH outcomes in an MSK population 
(not necessarily with MH conditions) was for MBSR/
meditation/meditative movement/mindfulness. Tai chi 
and yoga were effective for MSK and MH conditions 
in separate SRs (not comorbid populations). Our 2017 
update found new (but poor quality) evidence for yoga in 
MSK–MH comorbidity and more evidence for mindful-
ness in MSK–MH comorbidity.
Some of these studies showed effectiveness compared 
with an active comparator (spinal manipulation/mobili-
sation and yoga for LBP; meditation for depression and 
anxiety), providing some evidence that these interven-
tions have effects over and above non-specific attention.
The quality of the SRs was very variable. We used a 
quality tool, AMSTAR, which itself has some limitations, 
as it includes both methodological and reporting items 
which are not all necessarily equal in importance, and 
some of which can be difficult to interpret. Future reviews 
may consider prioritising certain items on AMSTAR, 
using the new version of AMSTAR,156 or using an alter-
native critical appraisal tool such as the Oxford Centre 
for Evidence-based Medicine checklist (https://www. 
cebm. net/ 2014/ 06/ critical- appraisal/). An assessment 
of risk of bias, using, for example, Risk Of Bias In System-
atic reviews (ROBIS), may be useful in addition to these 
quality assessments.
The quality of included trials also varied greatly; it is 
notable that none of the MH SRs concluded that trial 
quality was ‘good’ overall. In addition, assessment of indi-
vidual RCT study quality is likely to have varied between 
SR authors, a common issue with complementary medi-
cine studies which rarely fit conventional quality criteria 
(particularly blinding). Very few of the MSK SRs and 
none of the MH SRs mentioned cost-effectiveness. Safety 
was rarely adequately reported in SRs or the studies they 
included. Future SRs in the areas of complementary 
medicine and MSK/MH need to ensure they include a 
priori design/protocol registration, a list of excluded 
studies and conflict of interest statements, and use dupli-
cate study selection and data extraction, assess publica-
tion bias and search for grey literature.
Both a strength and limitation of this scoping review 
was its comprehensive scope which included a wide range 
of complementary medicine approaches and types of 
MSK and MH condition, but limited the depth of analysis 
and discussion.
Other key strengths were the systematic searching tech-
niques, prioritising high-quality SRs using MeSH terms 
where possible, and search techniques to capture grey 
and unpublished literature. The whole project team was 
involved in independently screening the literature search 
results, although a limitation was that only one author 
conducted data extraction. We included a quality appraisal 
of the reviews, although time constraints meant this was 
an abbreviated assessment. One of the key limitations 
was the pragmatic decision to only include SRs, which 
may have led to the exclusion of some complementary 
medicines, and means results are subject to the limita-
tions of SR and trial methodology, study designs which 
are sometimes challenging for complementary medi-
cine.157–159 Another key limitation is our definition of 
complementary medicine as including a practitioner in its 
delivery (which relied on review authors reporting these 
details), which excluded over-the -counter products or 
self-care practices, herbal medicine in particular, but was 
necessary to limit the scope of the review to complemen-
tary medicine which may be appropriate for an integrated 
care model using referral from a general practitioner. We 
are aware that by excluding reviews published pre-2005, 
we may have excluded some topics. We were unable to 
include non-English publications.
Although complementary medicine is commonly used 
by patients in the UK,25 it is not widely available via the 
NHS. Given the high burden of MSK and MH conditions 
to individuals and society in the UK, and the prevalence 
of comorbidity, complementary medicine may be worth 
considering for some patients, where there is evidence of 
effectiveness, cost-effectiveness and safety.
One of the main aims of this study was to inform the 
design of a future trial to assess the effectiveness and 
cost-effectiveness of an integrated medicine approach 
for patients with comorbid MSK and MH disorders. We 
will combine the results of this review with the views 
of conventional and complementary medicine practi-
tioners, the public and NHS providers, to inform the final 
focus for an RCT. Our proposed trial would be pragmatic 
and focus on overall effectiveness, so interventions with 
evidence compared with any comparator are potential 
candidates.
SRs of complementary medicine consistently conclude 
that further high-quality trials are needed, with longer 
follow-up and larger sample sizes, assessing cost-effective-
ness and use of appropriate, sensitive, validated outcome 
measures.
Based on our criteria of study quality, safety, cost-ef-
fectiveness and evidence for MSK MH comorbidity, this 
scoping review suggests that the most promising comple-
mentary medicine for future research in the area of MH–
MSK comorbidity are: mindfulness (evidence for MH in 
MSK populations and evidence of safety), yoga (evidence 
for MSK and MH conditions) and tai chi (evidence 
for MSK and MH conditions, evidence of safety). The 
comorbid populations that would benefit most are less 
clear, as so few reviews focus on comorbidity, but may 
include LBP, OA, depression, anxiety and sleep.
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